Translational Development Acquisition Corp. Ordinary Shares Cash Flow-to-Debt Ratio
Translational Development Acquisition Corp. Ordinary Shares cash flow-to-debt ratio. Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a Cash Flow-to-Debt Ratio of -0.04x as of June 2026, meaning its operating cash flow of $-338.75K could theoretically repay 0% of its total liabilities ($7.79 Million) in one year. Check TDAC operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Translational Development Acquisition Corp. Ordinary Shares (2022–2025)
Cash flow-to-debt ratio of Translational Development Acquisition Corp. Ordinary Shares from 2022 to 2025. Historical debt coverage capacity for Translational Development Acquisition Corp. Ordinary Shares across 4 annual periods. Also explore TDAC net asset momentum to track the company's year-over-year net asset growth rate.
Translational Development Acquisition Corp. Ordinary Shares Cash Flow-to-Debt Ratio by Year (2022–2025)
Translational Development Acquisition Corp. Ordinary Shares cash flow-to-debt ratio by year from 2022 to 2025. Year-by-year debt coverage analysis for Translational Development Acquisition Corp. Ordinary Shares. For the full cash flow conversion analysis, see Translational Development Acquisition Co operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.09x | $-608.39K | $6.58 Million | ▲ +32.2% |
| 2024 | -0.14x | $-851.45K | $6.25 Million | ▼ -33948.4% |
| 2023 | 0.00x | $-204.00 | $509.68K | ▲ +99.8% |
| 2022 | -0.21x | $-97.16K | $459.34K | — |